Active Pharmaceutical Ingredient Market to Grow with a CAGR of 6.77% through 2031

Surge in research and development activities is expected to drive the Global Active Pharmaceutical Ingredient Market growth in the forecast period, 2026-2031.

According to TechSci Research report, “Active Pharmaceutical Ingredient Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2031F”, the Global Active Pharmaceutical Ingredient Market stood at USD 155.41 Billion in 2024 and is anticipated to grow with a CAGR of 6.77% through 2031. Initiatives taken by government based on active pharmaceutical ingredient has led to favorable market conditions for the Global Active Pharmaceutical Ingredient Market. Several factors contribute to the growth of various active pharmaceutical ingredient products.

One of the major impacts of intensified R&D efforts is the expansion of therapeutic areas being addressed through pharmaceuticals. The rising focus on complex conditions such as cancer, autoimmune disorders, rare diseases, and neurodegenerative illnesses is leading to the discovery of more sophisticated APIs that require advanced synthesis techniques and biological manufacturing platforms. This trend is driving innovation in both synthetic and biotech API segments. In addition, R&D activities are enhancing production efficiency and product quality. Advanced technologies such as continuous manufacturing, green chemistry, and process intensification are being adopted to streamline API production, reduce waste, and lower environmental impact. This shift is also being reinforced by large-scale industry investment, with Novartis announcing a 23 billion dollar plan across 10 US facilities in 2025 covering both API and biologics drug substance production, highlighting how leading drug makers are expanding advanced manufacturing capacity for complex therapies.

One of the most impactful government interventions has been the promotion of domestic API manufacturing through dedicated funding, subsidies, and policy frameworks. Countries such as India, the United States, and several European nations have launched targeted programs to incentivize local API production. For example, India’s Production Linked Incentive Scheme for APIs provides financial support and infrastructure development to reduce import dependence and enhance local manufacturing capabilities for key starting materials and bulk drugs. The scale of this policy push is evident in India, where local manufacturing of 35 APIs across 32 plants had already started under the scheme for 53 critical APIs that previously faced around 90% import dependence.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Active Pharmaceutical Ingredient Market”

The Global Active Pharmaceutical Ingredient Market is segmented into type of synthesis, application, regional distribution, and company.

Based on Type of Synthesis, Fermentation have emerged as the dominating segment in the Global Active Pharmaceutical Ingredient Market in 2024. One of the key reasons behind the dominance of fermentation is its proven effectiveness in producing APIs derived from microorganisms, such as antibiotics such as penicillin and erythromycin, enzymes, hormones, and certain anticancer agents. These APIs often require specific biosynthetic pathways that can only be activated or maintained through microbial fermentation. This process allows for the cultivation of bacteria, fungi, or yeast in controlled environments to produce desired bioactive compounds with high purity and consistency. Fermentation remains central to commercial API production, as the American Chemical Society notes that Pfizer’s deep-tank fermentation breakthrough enabled industrial-scale penicillin manufacturing and later supported the production of additional antibiotic drugs, demonstrating the enduring value of microbial synthesis for complex active ingredients.

Based on Region, Asia Pacific have emerged as the fastest growing region in the Global Active Pharmaceutical Ingredient Market in 2024. This is fueled by its strong manufacturing base, cost advantages, and rapidly expanding pharmaceutical demand. Countries like India and China have established themselves as global hubs for API production, offering large-scale manufacturing capabilities, skilled labor, and favorable regulatory frameworks that enable cost-efficient operations and high export volumes. In addition to their production capacity, these countries are increasingly focusing on regulatory compliance, with many API facilities receiving approvals from stringent authorities such as the USFDA and EMA. This strength is reflected in India manufacturing more than 500 APIs and contributing 57% of APIs in the WHO prequalified list, while WuXi AppTec reported that its Changzhou API site supports 21 FDA-approved products and passed a 2025 FDA inspection with no observations.

Major companies operating in Global Active Pharmaceutical Ingredient Market are:

• Teva Pharmaceutical Industries Ltd.
• Bristol-Myers Squibb Company
• Boehringer Ingelheim GmbH
• Merck & Co., Inc.
• GlaxoSmithKline Plc
• Novartis International AG
• F. Hoffmann-La Roche AG
• Sanofi S.A.
• Eli Lilly and Company
• AbbVie Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report

“One of the most significant contributions of nanotechnology lies in enhancing solubility and absorption. Many modern APIs, particularly those used in oncology, anti-infectives, and central nervous system disorders, are poorly water-soluble, which limits their bioavailability. Nanoparticle engineering enables the formulation of these APIs into nanoemulsions, nanocrystals, or solid lipid nanoparticles, significantly improving their dissolution rates and enabling more consistent absorption across diverse patient populations”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Active Pharmaceutical Ingredient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Synthesis (Biotech, Fermentation, Plant Extracts, Synthetic), By Application (Cardiovascular Disease, Oncology, Neurological Disorders, Orthopedic Disorders, Respiratory, Gastrointestinal Disorders, Urology, Others), By Region and Competition, 2020-2031F”, has evaluated the future growth potential of Global Active Pharmaceutical Ingredient Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Active Pharmaceutical Ingredient Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com